483 Taro Pharmaceuticals U.S.A. Dec 2014

483 Taro Pharmaceuticals U.S.A. Dec 2014

Helen Ricalde FDA$119.00 - Available Now

FDA investigators audited the Taro Pharmaceuticals U.S.A. - Hawthorne, NY, United States facility and issued 3 inspectional observations (via FDA 483) on 19 Dec 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 3
  • Inspection end: 19 Dec 2014
  • Location: Hawthorne, United States
  • FEI: 2435212
Add To Cart